Is laterality prognostic in resected KRAS-mutated colorectal liver metastases? A systematic review and meta-analysis Review


Authors: Belias, M.; Sasaki, K.; Wang, J.; Andreatos, N.; Kamphues, C.; Kyriakos, G.; Seeliger, H.; Beyer, K.; Kreis, M. E.; Margonis, G. A.
Review Title: Is laterality prognostic in resected KRAS-mutated colorectal liver metastases? A systematic review and meta-analysis
Abstract: Background: It is debated whether primary tumor laterality (PTL) is prognostic in all patients with colorectal liver metastases (CRLM) or only those with KRAS wild-type or KRAS-mutated tumors; Methods: We systematically reviewed PubMed for studies reporting on resected CRLM originating from left-sided (LS) versus right-sided (RS) colon cancer stratified by KRAS status. Individual participant data (IPD) were used if available. Given that there are two definitions of PTL, we performed two meta-analyses for KRAS-mutated and two for wild-type patients. To assess if an interaction underlies the possible difference between the effects of PTL in KRAS-mutated vs. wild-type CRLM, we similarly performed two meta-analyses of interaction terms; Results: The meta-analyses included eight studies and 7475 patients. PTL had a prognostic association with OS in patients with wild-type tumors (HR for LS: 0.71 [0.60–0.84]), but not in those with KRAS-mutated tumors (HR: 0.99 [0.82–1.19]). This difference stemmed from a truly variable effect of PTL for each KRAS status (mutated vs. wild-type) as the meta-analysis of interaction terms showed a significant interaction between them (HR:1.38 [1.24–1.53]). Similar results were obtained when the second definition of PTL (LS to not include the rectum) was used; Conclusions: KRAS status modifies the association of tumor site with survival. Right-sided tumors are associated with worse OS only in patients with wild-type CRLM. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords: colorectal liver metastases; laterality; primary tumor location; kras mutated; kras wild type
Journal Title: Cancers
Volume: 14
Issue: 3
ISSN: 2072-6694
Publisher: MDPI  
Date Published: 2022-02-01
Start Page: 799
Language: English
DOI: 10.3390/cancers14030799
PROVIDER: scopus
PMCID: PMC8833748
PUBMED: 35159066
DOI/URL:
Notes: Review -- Export Date: 1 March 2022 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors